tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

XENE Stock Latest News

Xenon Pharmaceuticals Appoints Darren Cline as Chief Commercial Officer to Drive Commercial Launch
Company AnnouncementsXenon Pharmaceuticals Appoints Darren Cline as Chief Commercial Officer to Drive Commercial Launch
2d ago
XENE
Xenon Pharmaceuticals appoints Cline as Chief Commercial Officer
PremiumThe Fly
Xenon Pharmaceuticals appoints Cline as Chief Commercial Officer
2d ago
XENE
Positive Outlook for Xenon Pharmaceuticals Driven by Promising Drug Pipeline and Strategic Trial Developments
PremiumRatings
Positive Outlook for Xenon Pharmaceuticals Driven by Promising Drug Pipeline and Strategic Trial Developments
15d ago
XENE
Xenon Shareholders Approve Key Proposals at Annual Meeting
PremiumCompany Announcements
Xenon Shareholders Approve Key Proposals at Annual Meeting
21d ago
8K
XENE
Xenon Pharmaceuticals to Present at Global Healthcare Conference
PremiumCompany Announcements
Xenon Pharmaceuticals to Present at Global Healthcare Conference
23d ago
XENE
Xenon Pharmaceuticals Announces Equity Inducement Grants for New Employees
PremiumCompany AnnouncementsXenon Pharmaceuticals Announces Equity Inducement Grants for New Employees
27d ago
XENE
Xenon Pharmaceuticals’ Earnings Call Highlights Progress and Optimism
Premium
Company Announcements
Xenon Pharmaceuticals’ Earnings Call Highlights Progress and Optimism
1M ago
XENE
Xenon’s Azetukalner: Strong Phase 2b Data and Financial Stability Support Buy Rating Despite Trial Delays
Premium
Ratings
Xenon’s Azetukalner: Strong Phase 2b Data and Financial Stability Support Buy Rating Despite Trial Delays
1M ago
XENE
Xenon Pharmaceuticals to Present at 2025 RBC Healthcare Conference
PremiumCompany Announcements
Xenon Pharmaceuticals to Present at 2025 RBC Healthcare Conference
1M ago
XENE
Xenon Pharmaceuticals price target lowered to $60 from $62 at Stifel
PremiumThe Fly
Xenon Pharmaceuticals price target lowered to $60 from $62 at Stifel
1M ago
XENE
Xenon Pharmaceuticals price target lowered to $55 from $58 at RBC Capital
PremiumThe Fly
Xenon Pharmaceuticals price target lowered to $55 from $58 at RBC Capital
1M ago
XENE
Xenon Pharmaceuticals price target lowered to $47 from $50 at Wells Fargo
PremiumThe Fly
Xenon Pharmaceuticals price target lowered to $47 from $50 at Wells Fargo
1M ago
XENE
Confident Buy Rating for Xenon Amid X-TOLE2 Study Delays and Promising Azetukalner Results
PremiumRatingsConfident Buy Rating for Xenon Amid X-TOLE2 Study Delays and Promising Azetukalner Results
1M ago
XENE
Xenon Pharmaceuticals Advances Clinical Programs Amid Financial Loss
Premium
Company Announcements
Xenon Pharmaceuticals Advances Clinical Programs Amid Financial Loss
1M ago
XENE
Xenon Pharmaceuticals: Strong Buy Rating Amid Promising Clinical Trials and Financial Stability
Premium
Ratings
Xenon Pharmaceuticals: Strong Buy Rating Amid Promising Clinical Trials and Financial Stability
1M ago
XENE
Closing Bell Movers: Coinbase jumps after inclusion into S&P500
PremiumThe Fly
Closing Bell Movers: Coinbase jumps after inclusion into S&P500
1M ago
ZI
GCT
Xenon Pharmaceuticals Reports Q1 2025 Results and Advances Clinical Pipeline
PremiumCompany Announcements
Xenon Pharmaceuticals Reports Q1 2025 Results and Advances Clinical Pipeline
1M ago
XENE
Xenon Pharmaceuticals reports Q1 EPS (83c), consensus (90c)
PremiumThe Fly
Xenon Pharmaceuticals reports Q1 EPS (83c), consensus (90c)
1M ago
XENE
XENE Earnings this Week: How Will it Perform?
PremiumPre-Earnings
XENE Earnings this Week: How Will it Perform?
2M ago
XENE
AMD upgraded, Electronic Arts downgraded: Wall Street’s top analyst calls
PremiumThe FlyAMD upgraded, Electronic Arts downgraded: Wall Street’s top analyst calls
2M ago
EA
AMD
Xenon Pharmaceuticals initiated with a Buy at Chardan
Premium
The Fly
Xenon Pharmaceuticals initiated with a Buy at Chardan
2M ago
XENE
Xenon Pharmaceuticals to Announce Q1 2025 Financial Results
Premium
Company Announcements
Xenon Pharmaceuticals to Announce Q1 2025 Financial Results
2M ago
XENE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >